ABSTRACT We have reported previously that various edible protein digests inhibit dietary hyperlipidemia in mice, rats, pigs and dogs. Of the various digests tested, globin digest had the most potent inhibitory activity, and a tetrapeptide extracted from globin digest, Val-Val-Tyr-Pro, had activity 7000-fold greater than that of the parent digest. In this clinical study, we investigated the influence of globin digest on serum chylomicron triglyceride concentrations as an indicator of the effect of globin digest on fat absorption and catabolism in humans. Parallel and crossover trials were conducted in which men consumed a control high fat diet (25 g fat, 7.6 g carbohydrate, 1.9 g protein and 0.7 g sodium chloride) or the same diet supplemented with globin digest. The supplemented dosages were 1 and 4 g globin digest. In the parallel trial, 22 men were divided into three groups: control, globin digest 1 g and globin digest 4 g. The increases in chylomicron triglyceride concentrations at 1 h after ingestion of 1 or 4 g globin digest were significantly lower (P õ 0.05) compared with the control group. The crossover trial involved six subjects who consumed the control high fat diet and the same diet supplemented with 4 g globin digest. Serum chylomicron triglyceride levels increased in both groups at 1 and 2 h after ingestion, but when subjects consumed 4 g globin digest the increases were suppressed to 75 (P õ 0.05) and 42% (P õ 0.05) of the increases in controls at the corresponding times, respectively. The areas under the curves of chylomicron and serum total triglyceride concentrations during the 4 h after ingestion of 4 g globin digest were 46 (P õ 0.05) and 34% (P õ 0.05) lower, respectively, than when the men consumed the high fat control diet. In these trials, globin digest reduced the increase in serum chylomicron triglyceride concentrations as a result of the ingestion of a high fat diet. This hypotriglyceridemic effect of globin digest may be valuable for preventing obesity and in lowering the incidence of cardiovascular diseases. J. Nutr. 128: 56-60, 1998.
Serum cholesterol concentration is one of the risk factors some oligopeptides having 3-8 amino acid residues were for developing cardiovascular disease. In many epidemiologic shown to be hypotriglyceridemic (Kagawa 1990) . Oligopepstudies (Austin 1989, Carlson et al. 1979, Carlson and Böt- tides were prepared by suitable protease digestion of various tinger 1985, Castelli 1986), however, serum triglyceride level edible proteins such as globin, casein or soybean (EU patent is regarded as an independent risk factor for coronary heart no. WO 89/06970). Globin digest (GD) 4 demonstrated hypodisease. Furthermore, a high postprandial triglyceride level may triglyceridemic function superior to that of the other protein also be a risk factor for atherosclerotic disease (Groot et al. digests after fat ingestion in mice, rats and dogs in minute 1991, Patsch et al. 1992 , Simons et al. 1987 . These findings doses compared with the usual protein intake. A peptide, Valsuggest that lowering the serum triglyceride level may be more
Val-Tyr-Pro, which is present in GD, had 7000-fold greater important than lowering cholesterol concentration in the prehypotriglyceridemic activity than GD (Kagawa et al. 1996) . vention of cardiovascular disease and obesity.
Globin digest and Val-Val-Tyr-Pro inhibited fat absorption In our studies of lipid absorption, we have been trying to from the digestive tract and enhanced the activity of hepatic identify effective hypotriglyceridemic products. Recently, triglyceride lipase (EC 3.1.1.3) in mice. Oral administration of GD and olive oil enhanced the hepatic free fatty acid (FFA) concentrations compared with that found in mice adminis-1 Presented in part at the annual congress of the Japanese Society of Nutrition tered olive oil (Kagawa et al. 1996) . However, neither repres- The costs of publication of this article were defrayed in part by the payment 4 Abbreviations used: AUC, area under the curve; C, control high fat diet; FFA, free fatty acid; GD, globin digest: GD-1, the control diet supplemented with of page charges. This article must therefore be hereby marked ''advertisement'' in accordance with 18 USC section 1734 solely to indicate this fact. 1 g globin digest; GD-4, the control diet supplemented with 4 g globin digest; HTGL, hepatic triglyceride lipase. 3 To whom correspondence and reprint requests should be addressed. Serum triglyceride concentrations of 22 subjects were measured on the day before the parallel trial. Participants were divided into the three groups: control (C), GD-1 and GD-4 on the basis of the triglyceride concentrations. On the morning of the clinical trial, blood was collected again for a base-line analysis from the participants who had fasted for 12 h. Groups did not differ significantly (P ú 0.05).
2 Control diet (C) consisted of 25 g fat, 1.9 g protein, 7.6 g carbohydrate and 0.7 g sodium chloride (total energy 1.15 MJ). The two experimental diets were the same diet supplemented with 1 g (GD-1) and 4 g (GD-4) globin digest, respectively.
Abbreviations used: FFA, free fatty acids; GOT, glutamate oxaloacetate transaminase; GPT, glutamate pyruvate transaminase; g-GTP, g-glutamyltranspeptidase; GD-1, 1 g globin digest; GD-4, 4 g globin digest.
periods were 8 d apart. Blood was collected for a base-line analysis gastric emptying was caused by GD intake (Kagawa 1990, of serum lipids and hepatic enzyme activities in each period before Kagawa et al. 1996) . In this study, the suppressive effect of GD on postprandial concentrations were determined by enzymatic methods using comhyperlipidemia was examined in male human volunteers.
mercial kits (Triglyceride E-test, NEFA C-test, Cholesterol E-test, and HDL Cholesterol-test, Wako Pure Chemicals, Osaka, Japan).
SUBJECTS AND MATERIALS
Remnant lipoprotein was separated from the unbound serum fraction with monoclonal anti-B-100 and anti-apolipoprotein A-I immunoafVolunteers and diet. This study was conducted in compliance finity mixed gels (diagnostic kit, JIMRO, Otsuka Pharmaceutical, with the Declaration of Helsinki. All clinical investigations were Tokushima, Japan), which consisted of chylomicron remnants with conducted in the Second Department of Medical Biochemistry, apo lipoprotein B-48. Serum glutamate oxaloacetate transaminase School of Medicine, Ehime University.
(EC 2.6.1.1) and glutamate pyruvate transaminase (EC 2.6.1.2) were Healthy male volunteers aged 20-24 y signed an informed consent measured by Reitman-Frankel methods (Reitman and Frankel 1957) form. After overnight fasting (Ç12 h), the subjects were given 100 with the use of a commercial kit (S.T.A-test, Wako). Serum gmL of thick cream soup to which was added 24 g butter (control glutamyltranspeptidase (EC 2.3.2.2) was also determined by using a diet) or the same meal supplemented with GD. The subjects fasted commercial kit (g-GTP-test, Wako) using L-g-glutamyl-p-N-ethylfor 4 h after the meal but had free access to water. The control diet N-hydroxyethylaminoanilidine as a substrate. consisted of 1.9 g protein, 25 g fat, 7.6 g carbohydrate and 0.7 g Pharmacodynamic analysis of elimination velocity of chylomicron sodium chloride (total energy 1.15 MJ). The supplemented dosages triglyceride. Absorption and elimination rates of chylomicron triof GD were 1 g (GD-1 diet) and 4 g (GD-4 diet). Globin digest glyceride in the crossover were calculated with the use of equations (Hankyu Kyoei Bussan, Osaka, Japan) is an oligopeptide mixture of the one-compartment model (Benet and Sheiner 1985) . produced from enzymatic hydrolysis of bovine RBC and contains 93% Statistical analysis. Data were expressed as means { SEM. protein. The oligopeptides consist of 3-5 amino acid residues. The Changes in triglyceride concentration from initial levels in both parmolecular size of the constituted peptides is distributed among molecallel and crossover trials were analyzed by repeated measures ANular weights ranging from 100 to 1500. The content of free amino OVA. One-way (diet) ANOVA was used in the parallel design trial; acids was 10%.
if the F test was significant, Fisher's protected least significant differStudy design. Parallel and crossover trials were conducted to evalence test (Steel and Torrie 1980) was used to detect significantly uate the hypotriglyceridemic effect of GD. different means. These analyses were performed by the statistics proIn the parallel trial, serum total triglyceride concentrations of 22 grams of Yanai and Nagata (1994) using macro commands of Lotus subjects were analyzed on the morning of the day before the clinical 1-2-3 (Lotus Development, Cambridge, MA). The analysis of the trial. Participants were divided into three groups: control, GD-1 and crossover design trial was accomplished by two-way (diet and time) GD-4 on the basis of the triglyceride concentrations. On the morning ANOVA (Wagner 1975) . Differences in the elimination and absorpof the clinical trial, body weights and heights of the subjects were tion rate constants were analyzed by the parallel line assay method measured; then blood was collected again before intake of the diet (Finney 1964) . Differences were considered significant at P õ 0.05. for a base-line analysis. Serum lipids of the three groups were not significantly different (Table 1) .
After the parallel trial, six additional subjects participated in a
RESULTS AND DISCUSSION
crossover trial in which they consumed both the high fat control and
Characteristics of the subjects involved in the parallel study GD-4 diets. Three subjects consumed the high fat control diet first while the others consumed the GD-supplemented diet. The two diet are summarized in lomicron triglyceride concentrations at 1-3 h after ingestion of the control diet were significantly increased relative to basediffer among the three groups. The activities of serum glutamate oxaloacetate transaminase, glutamate pyruvate transamiline values (P õ 0.05) (Fig. 2) . When subjects consumed the GD-4 diet, serum total and chylomicron triglyceride concennase and g-glutamyltranspeptidase, indicators of hepatic function, were within normal ranges. There were four subjects with trations at 2 and 3 h, respectively, were significantly increased relative to base-line values (P õ 0.05). The increases in chyhyperlipidemia. Two individuals had hypercholesterolemia (range, 5.70-6.44 mmol/L) and another two had hypertriglyclomicron triglyceride concentration were suppressed to 75 (P õ 0.05) and 42% (P õ 0.05) of the increases that occurred eridemia (range, 1.47-1.72 mmol/L). These two subjects were separated into the control and GD-4 groups.
when they consumed the control high fat diet at 1 and 2 h postingestion, respectively. The increases in serum total triSerum total and chylomicron triglyceride concentrations at 1-3 h after ingestion of the control diet were significantly glyceride concentrations at 1 h after ingestion of the GD-4 diet were significantly lower (P õ 0.05) than the increase in increased relative to base-line values (P õ 0.05) (Fig. 1) . Triglyceride concentrations peaked 2-3 h after ingestion. subjects who consumed the control diet. Areas under the triglyceride concentration curves for 4 h When subjects consumed the GD-1 or GD-4 diet, the serum total and chylomicron triglyceride concentrations at 2 and 3 (AUC 0-4 h) were calculated for subjects in both the parallel and crossover trials ( Table 3 ). In the parallel trial, no signifih, respectively, were significantly increased relative to baseline values (P õ 0.05). The increases in chylomicron triglycercant differences among groups were observed in the AUC of serum total or chylomicron triglycerides because of large ide concentrations at 1 h after ingestion of the GD-1 or GD-4 diet were significantly lower (P õ 0.05) than the increase variation among the participants. However, the AUC of serum total and chylomicron triglyceride concentrations when subin subjects who consumed the control diet. No significant differences in the magnitude of changes in serum total triglycjects consumed the GD-4 diet in the crossover trial were significantly lower, by 34 (P õ 0.05) and 46% (P õ 0.05), eride concentrations were observed among the three groups.
Serum lipids and hepatic enzyme activities of participants respectively, than when they consumed the control diet.
To determine the influence of GD on chylomicron metaboin the crossover trial were within normal ranges ( Table 2) . Serum total triglyceride concentrations at 2 and 3 h and chylism, absorption and elimination rate, constants were calcu- lated from the chylomicron triglyceride concentrations in subwere too low to quantify. However, changes in chylomicron remnant concentrations were detected in two subjects (Fig. jects in the crossover trial by using the one-compartment model ( Table 4) . No significant differences in magnitude of 3). At 1 and 2 h after ingestion of the GD-4 diet, chylomicron remnant concentrations in these two men appeared to be lower changes for the absorption and elimination rate constants of chylomicron triglycerides were observed between subjects that than when they consumed the high fat control diet. Oral administration of GD in mice did not affect lipoprotein lipase consumed the control and GD-4 diets.
Postprandial serum levels of remnant lipoproteins are reactivity (Fukuhama et al. 1991) . We have also reported that GD induced hepatic triglyceride lipase (HTGL) activity in garded as an indicator of hepatic uptake of chylomicron remnants. High chylomicron remnant level after fat ingestion is mice (Kagawa et al. 1996) . Chylomicron remnant was digested by HTGL and resulted in the formation of FFA, which were a risk factor for cardiovascular disease (Campos et al. 1992 , Groot et al. 1991 , Patsch et al. 1991 , Simons et al. 1987 .
observed in vitro and in vivo in human studies (Murase and Itakura 1981, Nicoll and Lewis 1980) . Ingestion of a high fat Chylomicron remnant concentrations in the most subjects diet with GD may increase hepatic FFA concentrations. Oral administration of GD with olive oil to mice enhanced hepatic  TABLE 4 FFA concentration in the early phase (Kagawa et al. 1996) . (Wagner 1975) as follows: Concentration of chylomicron triglyceride (C) Å C 0abs re 0kabsr t / C 0el re 0kelrt Symbols C 0 , k abs , k el and r represent the initial concentration, coefficient of absorption, coefficient of elimination and coefficient of regression curve, respectively. The crossover trial was taken between a control diet (Control) and the same diet supplemented with 4 g globin digest (GD-4). The control diet consisted of 25 g fat, 1.9 g protein, 7.6 g carbohydrate and 0.7 g sodium chloride (total energy 1.15 MJ).
2 Absorption and elimination rates were calculated from 0-2 h and 2-4 h of chylomicron triglyceride concentrations (means of 6 subjects FIGURE 3 Changes in chylomicron remnant concentrations in showed in Figure 2 ), respectively. men after ingestion of the high fat control diet (Control) and the same 3 Differences in elimination and absorption rate constants were anadiet supplemented with 4 g globin digest (GD-4) in the crossover trial. lyzed by the parallel line assay method (Finney 1964) . No differences Values are means of 2 subjects. The chylomicron remnant concentrawere significant. 4 Coefficient of regression curve. tions of the other participants were too low to quantify.
